|
Volumn 23, Issue 5, 2005, Pages 1045-1046
|
First, do no harm; second, make sure you are doing some good [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
LETROZOLE;
PREDNISONE;
RITUXIMAB;
TAMOXIFEN;
TRASTUZUMAB;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ADJUVANT THERAPY;
BREAST CANCER;
CANCER;
CANCER SURGERY;
CANCER SURVIVAL;
CANCER THERAPY;
CHEMOTHERAPY;
COMBINATION CHEMOTHERAPY;
HEALTH CARE QUALITY;
HUMAN;
LETTER;
LYMPHOMA;
MEDICAL PRACTICE;
ONCOLOGY;
PRIORITY JOURNAL;
BIOASSAY;
CLINICAL TRIAL;
ETHICS;
MEDICAL ETHICS;
METHODOLOGY;
NOTE;
PATIENT ADVOCACY;
QUALITY OF LIFE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
ENDPOINT DETERMINATION;
ETHICS, MEDICAL;
HUMANS;
PATIENT ADVOCACY;
QUALITY OF LIFE;
RESEARCH DESIGN;
|
EID: 14644430394
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.05.126 Document Type: Letter |
Times cited : (3)
|
References (2)
|